A close study of one patient-reported outcome has deemed it a clinically valuable measure, according to a study published in the Journal of the American College of Surgeons.
Although the clinical value of patient-reported outcomes (PROs) has been debated, a close study of one PRO has deemed it a clinically valuable measure, according to a study published in the Journal of the American College of Surgeons.
The study examined the association of readiness for discharge from the hospital with patient satisfaction and readmission. The researchers used post-discharge surveys for 220 patients admitted for small bowel obstruction and 98 patients with hospitals stays of 21 days or longer. The created 2 groups: those who said they felt ready for discharge and those with lesser degrees of readiness.
The 30-day readmission rate was 14.3% and 55% indicated they were ready for discharge. Overall, the 2 groups had similar demographics, comorbidity scores, and rates of surgery. However, the investigators found that those ready for discharge had higher overall hospital satisfaction, higher physician communication scores, and higher nursing communication scores. Notably, readmission rates were similar between the groups.
“Readiness for discharge appears to be a clinically useful patient-reported metric, as those [ready for discharge] have higher satisfaction with the hospital and physicians,” the authors concluded.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More